Neurana Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Neurana Pharmaceuticals's estimated annual revenue is currently $310k per year.
- Neurana Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Neurana Pharmaceuticals has 2 Employees.
- Neurana Pharmaceuticals grew their employee count by -50% last year.
Neurana Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Research | Reveal Email/Phone |
3 | President/CEO | Reveal Email/Phone |
4 | CMC, Manufacturing | Reveal Email/Phone |
Neurana Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Neurana Pharmaceuticals?
Neurana Pharmaceuticals is a privately held clinical stage San Diego based specialty pharmaceutical company developing a novel treatment for acute muscle spasms. The Company was founded in 2013 to focus on central nervous system (CNS) diseases and disorders. Neurana's first drug candidate is tolperisone, which has been shown to be an effective treatment for muscle spasms and spasticity and is commercialized in markets outside of the United States. Clinical studies and commercial usage have shown that tolperisone is safe and efficacious, and that the drug is non-sedating and non-addictive. In May 2018, Neurana completed a $60M Series A financing led by Sofinnova Ventures and included participation from New Leaf Venture Partners, H.I.G. BioHealth Partners, Longitude Capital and MagnaSci Ventures.
keywords:N/A
N/A
Total Funding
2
Number of Employees
$310k
Revenue (est)
-50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neurana Pharmaceuticals News
... executive of Neurana Pharmaceuticals, where a recent Phase III bellyflop with tolperisone cast a bleak outlook on the company's future.
... in the biotech and pharmaceutical industries to the company. ... most recently served as President and CEO at Neurana Pharmaceuticals,...
Joins from Neurana Pharma. Mr Thompson most recently served as president and CEO at Neurana Pharmaceuticals, a private company focused on the...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0M | 2 | -50% | $1.3M |
#2 | $0M | 2 | 0% | $2.2M |
#3 | $0.1M | 2 | 0% | N/A |
#4 | $0.2M | 2 | -50% | N/A |
#5 | N/A | 2 | 0% | N/A |